Copay coupons: there’s more to the story

The usual argument from pharmacy benefit managers (PBMs) is that copay coupons drive patients toward higher-cost, branded drugs, resulting in higher healthcare costs for insurers and ultimately patients themselves. The counterargument, from the manufacturers that offer them, is that the […]

Read More

More private equity flows into patient support services

Patient support services (aka hub providers) continues to experience the growth generated by high-touch (and, usually, high-cost) specialty pharmaceuticals, and the pharma industry’s demand for outsourcing these services. In early November, RxCrossroads’ ownership transferred from CVS Health to McKesson; now […]

Read More